1. Home
  2. Labeler Index
  3. Takeda Pharmaceuticals America, Inc.
  4. 68875-0204
  5. NDC Package Code: 68875-0204-2 Natpara (parathyroid Hormone)

NDC Package 68875-0204-2 Natpara (parathyroid Hormone)

Parathyroid Hormone Injection, Powder, Lyophilized, For Solution Subcutaneous - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
68875-0204-2
Package Description:
2 CARTRIDGE in 1 CARTON / 1.13 mL in 1 CARTRIDGE (68875-0204-1)
Product Code:
68875-0204
Proprietary Name:
Natpara (parathyroid Hormone)
Non-Proprietary Name:
Parathyroid Hormone
Substance Name:
Parathyroid Hormone
Usage Information:
This medication is a man-made form of parathyroid hormone, a natural substance made in your body by the parathyroid glands. Parathyroid hormone helps to regulate and maintain the balance of calcium and phosphorus in your body. This medication is used along with calcium and vitamin D to help control low blood calcium due to low levels of parathyroid hormone.
11-Digit NDC Billing Format:
68875020402
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
1 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 1602023 - parathyroid hormone 25 MCG/Dose in 14 Dose Cartridge
  • RxCUI: 1602023 - 14 ACTUAT parathyroid hormone 0.025 MG/ACTUAT Cartridge
  • RxCUI: 1602023 - parathyroid hormone 0.025 MG/ACTUAT Cartridge, 14 ACTUAT
  • RxCUI: 1602023 - parathyroid hormone 25 MCG/Dose Cartridge, 14 Doses
  • RxCUI: 1602028 - Natpara 25 MCG/Dose in 14 Dose Cartridge
    • Product Type:
    Human Prescription Drug
    Labeler Name:
    Takeda Pharmaceuticals America, Inc.
    Dosage Form:
    Injection, Powder, Lyophilized, For Solution - A dosage form intended for the solution prepared by lyophilization ("freeze drying"), a process which involves the removal of water from products in the frozen state at extremely low pressures; this is intended for subsequent addition of liquid to create a solution that conforms in all respects to the requirements for Injections.
    Administration Route(s):
  • Subcutaneous - Administration beneath the skin; hypodermic. Synonymous with the term SUBDERMAL.
    • Active Ingredient(s):
  • PARATHYROID HORMONE 75 ug/.08mL
    • Pharmacologic Class(es):
  • Parathyroid Hormone - [CS]
  • Parathyroid Hormone - [EPC] (Established Pharmacologic Class)
    • Sample Package:
    No
    FDA Application Number:
    BLA125511
    Marketing Category:
    BLA - A product marketed under an approved Biologic License Application.
    Start Marketing Date:
    01-23-2015
    Listing Expiration Date:
    12-31-2024
    Exclude Flag:
    N
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 68875-0204-2?

    The NDC Packaged Code 68875-0204-2 is assigned to a package of 2 cartridge in 1 carton / 1.13 ml in 1 cartridge (68875-0204-1) of Natpara (parathyroid Hormone), a human prescription drug labeled by Takeda Pharmaceuticals America, Inc.. The product's dosage form is injection, powder, lyophilized, for solution and is administered via subcutaneous form.This product is billed for "EA" each discreet unit and contains an estimated amount of 1 billable units per package.

    Is NDC 68875-0204 included in the NDC Directory?

    Yes, Natpara (parathyroid Hormone) with product code 68875-0204 is active and included in the NDC Directory. The product was first marketed by Takeda Pharmaceuticals America, Inc. on January 23, 2015 and its listing in the NDC Directory is set to expire on December 31, 2024 if the product is not updated or renewed by the manufacturer.

    What is the NDC billing unit for package 68875-0204-2?

    The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 1.

    What is the 11-digit format for NDC 68875-0204-2?

    The 11-digit format is 68875020402. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-4-1 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-4-168875-0204-25-4-268875-0204-02